Since June 23rd, 2014

Wednesday, September 23, 2015

More numbers

So yesterday a new drug was approved by the FDA for the treatment of metastatic (stage IV) colon cancer. So scary to me to see all of the excitement about a drug that increases overall survival by an average of 1.8 months.

I should be talking about decades and years, not months. Makes me want to scream and feel mad and frustrated. I haven't experienced that kind of emotion much during the last year, but that is how I'm starting today. I suppose I should be happy about all of the treatments available and the continued research and dedication of those involved, but it's just hard.

"In the RECOURSE study, the median overall survival (OS) for patients with mCRC who received TAS-102 was 7.1 months compared with 5.3 months with placebo (HR, 0.68; P <.0001). The median progression-free survival (PFS) in the TAS-102 arm was 2 months versus 1.7 months with placebo..."

No comments:

Post a Comment